Cytomegalievirusinfektion nach Nierentransplantation - Einsatz von Immunglobulinen kann die Entwicklung früher Non-Hodgkin-Lymphome verhindern

Literatur

• 01 EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment. Nephrol Dial Transplant 2002; 17 (suppl 4): 31-33, 35-36. 
• 02 Hopwood P . Crawford DH . The role of EBV in post-transplant malignancies: a review.  J Clin Pathol. 2000;  53 248-254
• 03 Opelz G . Daniel V . Naujokat C . et al . Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.  Lancet Oncol. 2007;  8 212-218
• 04 Opelz G . Döhler B . Lymphomas after solid organ transplantation: a collaborative transplant study report.  Am J Transplant. 2004;  4 222-230
• 05 Penn I . Hammond W . Brettschneider L . Starzl TE . Malignant lymphomas in transplantation patients.  Transplant Proc. 19969;  1 106-112
• 06 Starzl TE . Nalesnik MA . Porter KA . et al . Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.  Lancet. 1984;  1 583-587